You are currently viewing a new version of our website. To view the old version click .

3 Results Found

  • Article
  • Open Access
11 Citations
5,998 Views
9 Pages

Four Novel p.N385K, p.V36A, c.1033–1034insT and c.1417–1418delCT Mutations in the Sphingomyelin Phosphodiesterase 1 (SMPD1) Gene in Patients with Types A and B Niemann-Pick Disease (NPD)

  • Masoumeh Dehghan Manshadi,
  • Behnam Kamalidehghan,
  • Fatemeh Keshavarzi,
  • Omid Aryani,
  • Sepideh Dadgar,
  • Ahoora Arastehkani,
  • Mahdi Tondar,
  • Fatemeh Ahmadipour,
  • Goh Yong Meng and
  • Massoud Houshmand

24 March 2015

Background: Types A and B Niemann-Pick disease (NPD) are autosomal-recessive lysosomal storage disorders caused by the deficient activity of acid sphingomyelinase due to mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene. Methods: In ord...

  • Article
  • Open Access
29 Citations
8,063 Views
14 Pages

Analysis of CFTR Mutation Spectrum in Ethnic Russian Cystic Fibrosis Patients

  • Nika V. Petrova,
  • Nataliya Y. Kashirskaya,
  • Tatyana A. Vasilyeva,
  • Elena I. Kondratyeva,
  • Elena K. Zhekaite,
  • Anna Y. Voronkova,
  • Victoria D. Sherman,
  • Varvara A. Galkina,
  • Eugeny K. Ginter and
  • Sergey I. Kutsev
  • + 2 authors

15 May 2020

The distribution and frequency of the CFTR gene mutations vary considerably between countries and ethnic groups. Russians are an East Slavic ethnic groups are native to Eastern Europe. Russians, the most numerous people of the Russian Federation (RF)...

  • Article
  • Open Access
4 Citations
4,300 Views
13 Pages

Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

  • ErinMarie O. Kimbrough,
  • Julian A. Marin-Acevedo,
  • Leylah M. Drusbosky,
  • Ariana Mooradian,
  • Yujie Zhao,
  • Rami Manochakian and
  • Yanyan Lou

27 June 2024

Genomic mutations impact non-small cell lung cancer (NSCLC) biology. The influence of sex and age on the distribution of these alterations is unclear. We analyzed circulating-tumor DNA from individuals with advanced NSCLC from March 2018 to October 2...